159 related articles for article (PubMed ID: 38414527)
1. Efficient Sequential Co-Delivery Nanosystem for Inhibition of Tumor and Tumor-Associated Fibroblast-Induced Resistance and Metastasis.
Li C; Wang Z; Zhang Y; Zhu Y; Xu M; Lei H; Zhang D
Int J Nanomedicine; 2024; 19():1749-1766. PubMed ID: 38414527
[TBL] [Abstract][Full Text] [Related]
2. Targeting the cancer-associated fibroblasts as a treatment in triple-negative breast cancer.
Takai K; Le A; Weaver VM; Werb Z
Oncotarget; 2016 Dec; 7(50):82889-82901. PubMed ID: 27756881
[TBL] [Abstract][Full Text] [Related]
3. Co-Delivery Nanomicelles for Potentiating TNBC Immunotherapy by Synergetically Reshaping CAFs-Mediated Tumor Stroma and Reprogramming Immunosuppressive Microenvironment.
Zhang Y; Han X; Wang K; Liu D; Ding X; Hu Z; Wang J
Int J Nanomedicine; 2023; 18():4329-4346. PubMed ID: 37545872
[TBL] [Abstract][Full Text] [Related]
4. Biomimetic "nano-spears" for CAFs-targeting: splintered three "shields" with enhanced cisplatin anti-TNBC efficiency.
Wu Y; Chen R; Ni S; Hu K
J Control Release; 2024 Jun; 370():556-569. PubMed ID: 38697316
[TBL] [Abstract][Full Text] [Related]
5. Irinotecan/scFv co-loaded liposomes coaction on tumor cells and CAFs for enhanced colorectal cancer therapy.
Li Z; Liu C; Li C; Wang F; Liu J; Zheng Z; Wu J; Zhang B
J Nanobiotechnology; 2021 Dec; 19(1):421. PubMed ID: 34906155
[TBL] [Abstract][Full Text] [Related]
6. Bruceine D suppresses CAF-promoted TNBC metastasis under TNF-α stimulation by inhibiting Notch1-Jagged1/NF-κB(p65) signaling.
Chen H; Han X; Zhang Y; Wang K; Liu D; Hu Z; Wang J
Phytomedicine; 2024 Jan; 123():154928. PubMed ID: 38043386
[TBL] [Abstract][Full Text] [Related]
7. Tumor-Stroma-Inflammation Networks Promote Pro-metastatic Chemokines and Aggressiveness Characteristics in Triple-Negative Breast Cancer.
Liubomirski Y; Lerrer S; Meshel T; Rubinstein-Achiasaf L; Morein D; Wiemann S; Körner C; Ben-Baruch A
Front Immunol; 2019; 10():757. PubMed ID: 31031757
[TBL] [Abstract][Full Text] [Related]
8. Targeting therapy and tumor microenvironment remodeling of triple-negative breast cancer by ginsenoside Rg3 based liposomes.
Xia J; Zhang S; Zhang R; Wang A; Zhu Y; Dong M; Ma S; Hong C; Liu S; Wang D; Wang J
J Nanobiotechnology; 2022 Sep; 20(1):414. PubMed ID: 36109762
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic Response of Multifunctional Lipid and Micelle Formulation in Hepatocellular Carcinoma.
Wu J; Wang F; Dong J; Zhang S; Li N; Zhao H; Liu X; Gao Z; Zhang B; Tian G
ACS Appl Mater Interfaces; 2022 Oct; 14(40):45110-45123. PubMed ID: 36167351
[TBL] [Abstract][Full Text] [Related]
10. Acidic tumor microenvironment-sensitive liposomes enhance colorectal cancer therapy by acting on both tumor cells and cancer-associated fibroblasts.
Li C; Li Z; Gong X; Liu J; Zheng T; Wang F; Wu J; Zhang B
Nanoscale; 2021 Jun; 13(23):10509-10525. PubMed ID: 34096957
[TBL] [Abstract][Full Text] [Related]
11. Synchronous targeted delivery of TGF-β siRNA to stromal and tumor cells elicits robust antitumor immunity against triple-negative breast cancer by comprehensively remodeling the tumor microenvironment.
Yang M; Qin C; Tao L; Cheng G; Li J; Lv F; Yang N; Xing Z; Chu X; Han X; Huo M; Yin L
Biomaterials; 2023 Oct; 301():122253. PubMed ID: 37536040
[TBL] [Abstract][Full Text] [Related]
12. pH-responsive Sulfated Hyaluronic Acid Nanoparticles Targeting Tumor Cells and CAFs for the Treatment of Breast Cancer.
Wang D; Wu J; Qi C; Dong J; Ding X; Yu G; Liu S; Zhang B; Gao Z; Wei X; Liu H
Recent Pat Anticancer Drug Discov; 2022; 18(2):200-210. PubMed ID: 35538821
[TBL] [Abstract][Full Text] [Related]
13. Sensitizing Triple Negative Breast Cancer to Tamoxifen Chemotherapy via a Redox-Responsive Vorinostat-containing Polymeric Prodrug Nanocarrier.
Ma W; Sun J; Xu J; Luo Z; Diao D; Zhang Z; Oberly PJ; Minnigh MB; Xie W; Poloyac SM; Huang Y; Li S
Theranostics; 2020; 10(6):2463-2478. PubMed ID: 32194813
[TBL] [Abstract][Full Text] [Related]
14. Regulating cancer associated fibroblasts with losartan-loaded injectable peptide hydrogel to potentiate chemotherapy in inhibiting growth and lung metastasis of triple negative breast cancer.
Hu C; Liu X; Ran W; Meng J; Zhai Y; Zhang P; Yin Q; Yu H; Zhang Z; Li Y
Biomaterials; 2017 Nov; 144():60-72. PubMed ID: 28823844
[TBL] [Abstract][Full Text] [Related]
15. Thermosensitive Betulinic Acid-Loaded Magnetoliposomes: A Promising Antitumor Potential for Highly Aggressive Human Breast Adenocarcinoma Cells Under Hyperthermic Conditions.
Farcas CG; Dehelean C; Pinzaru IA; Mioc M; Socoliuc V; Moaca EA; Avram S; Ghiulai R; Coricovac D; Pavel I; Alla PK; Cretu OM; Soica C; Loghin F
Int J Nanomedicine; 2020; 15():8175-8200. PubMed ID: 33122905
[TBL] [Abstract][Full Text] [Related]
16. Isolation of Primary Cancer-Associated Fibroblasts from a Syngeneic Murine Model of Breast Cancer for the Study of Targeted Nanoparticles.
Truffi M; Sitia L; Sevieri M; Bonizzi A; Rizzuto MA; Mazzucchelli S; Corsi F
J Vis Exp; 2021 May; (171):. PubMed ID: 34057456
[TBL] [Abstract][Full Text] [Related]
17. Sequentially-targeted biomimetic nano drug system for triple-negative breast cancer ablation and lung metastasis inhibition.
Fan J; Liu B; Long Y; Wang Z; Tong C; Wang W; You P; Liu X
Acta Biomater; 2020 Sep; 113():554-569. PubMed ID: 32569637
[TBL] [Abstract][Full Text] [Related]
18. Her2-Targeted Multifunctional Nano-Theranostic Platform Mediates Tumor Microenvironment Remodeling and Immune Activation for Breast Cancer Treatment.
Zheng D; Wan C; Yang H; Xu L; Dong Q; Du C; Du J; Li F
Int J Nanomedicine; 2020; 15():10007-10028. PubMed ID: 33376321
[TBL] [Abstract][Full Text] [Related]
19. Prodrug polymeric micelles integrating cancer-associated fibroblasts deactivation and synergistic chemotherapy for gastric cancer.
Zheng S; Wang J; Ding N; Chen W; Chen H; Xue M; Chen F; Ni J; Wang Z; Lin Z; Jiang H; Liu X; Wang L
J Nanobiotechnology; 2021 Nov; 19(1):381. PubMed ID: 34802453
[TBL] [Abstract][Full Text] [Related]
20. Enhancing the Inhibition of Breast Cancer Growth Through Synergistic Modulation of the Tumor Microenvironment Using Combined Nano-Delivery Systems.
Wu J; Lu Q; Zhao J; Wu W; Wang Z; Yu G; Tian G; Gao Z; Wang Q
Int J Nanomedicine; 2024; 19():5125-5138. PubMed ID: 38855730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]